Messung des elektrischen Neutron-Formfaktors in der Reaktion 3 He(e,e'n)pp bei Q 2 = 1.58 (GeV/c) 2

Die elektromagnetischen Nukleon-Formfaktoren sind fundamentale Größen, welche eng mit der elektromagnetischen Struktur der Nukleonen zusammenhängen. Der Verlauf der elektrischen und magnetischen Sachs-Formfaktoren G_E und G_M gegen Q^2, das negative Quadrat des Viererimpulsübertrags im elektromagnetischen Streuprozess, steht über die Fouriertransformation in direkter Beziehung zu der räumlichen Ladungs- und Strom-Verteilung in den Nukleonen. Präzise Messungen der Formfaktoren über einen weiten Q^2-Bereich werden daher für ein quantitatives Verständnis der Nukleonstruktur benötigt.rnrnDa es keine freien Neutrontargets gibt, gestaltet sich die Messung der Neutron-Formfaktoren schwierig im Vergleich zu der Messung am Proton. Konsequenz daraus ist, dass die Genauigkeit der vorhandenen Daten von Neutron-Formfaktoren deutlich geringer ist als die von Formfaktoren des Protons; auch der vermessene Q^2-Bereich ist kleiner. Insbesondere der elektrische Sachs-Formfaktor des Neutrons G_E^n ist schwierig zu messen, da er aufgrund der verschwindenden Nettoladung des Neutrons im Verhältnis zu den übrigen Nukleon-Formfaktoren sehr klein ist. G_E^n charakterisiert die Ladungsverteilung des elektrisch neutralen Neutrons und ist damit besonders sensitiv auf die innere Struktur des Neutrons.rnrnIn der hier vorgestellten Arbeit wurde G_E^n aus Strahlhelizitätsasymmetrien in der quasielastischen Streuung vec{3He}(vec{e}, e'n)pp bei einem Impulsübertrag von Q^2 = 1.58 (GeV/c)^2 bestimmt. Die Messung fand in Mainz an der Elektronbeschleunigeranlage Mainzer Mikrotron innerhalb der A1-Kollaboration im Sommer 2008 statt. rnrnLongitudinal polarisierte Elektronen mit einer Energie von 1.508 GeV wurden an einem polarisierten ^3He-Gastarget, das als effektives, polarisiertes Neutrontarget diente, gestreut. Die gestreuten Elektronen wurden in Koinzidenz mit den herausgeschlagenen Neutronen detektiert; die Elektronen wurden in einem magnetischen Spektrometer nachgewiesen, durch den Nachweis der Neutronen in einer Matrix aus Plastikszintillatoren wurde der Beitrag der quasielastischen Streuung am Proton unterdrückt.rnrnAsymmetrien des Wirkungsquerschnitts bezüglich der Elektronhelizität sind bei Orientierung der Targetpolarisation in der Streuebene und senkrecht zum Impulsübertrag sensitiv auf G_E^n / G_M^n; mittels deren Messung kann G_E^n bestimmt werden, da der magnetische Formfaktor G_M^n mit vergleichsweise hoher Präzision bekannt ist. Zusätzliche Messungen der Asymmetrie bei einer Polarisationsorientierung parallel zum Impulsübertrag wurden genutzt, um systematische Fehler zu reduzieren.rnrnFür die Messung inklusive statistischem (stat) und systematischem (sys) Fehler ergab sich G_E^n = 0.0244 +/- 0.0057_stat +/- 0.0016_sys.

Reattachment of the tuberosities with cable wires and bone graft in hemiarthroplasties done for proximal humeral fractures with cable wire and bone graft: 58 patients with a 22-month minimum follow-up

OBJECTIVE: The stability of 2 fixation techniques for the tuberosities in patients with 3- or 4-part proximal humerus fractures treated with hemiarthroplasties was compared. DESIGN: Retrospective review of a nonrandomized sequential series of patients. SETTING: Level I university orthopaedic surgery department. PATIENTS: A consecutive series of 58 patients (average age, 64 years) from 1990 to 1999 with 3- and 4-part fractures of the proximal humerus. INTERVENTION: In group 1, 31 patients were treated with either a Neer or Aequalis shoulder prosthesis using nonabsorbable sutures and no bone graft for the reattachment of the tuberosities. In group 2, 27 patients were treated with either an Aequalis or Epoca shoulder prosthesis and a combination of cable fixation and bone grafting. MAIN OUTCOME MEASUREMENTS: At follow-up (average, 32 months), radiographs were taken to confirm tuberosity fixation or degree of displacement or resorption. Functional outcome was assessed by the Constant-Murley Score. RESULTS: Significantly more dislocated tuberosities were found radiographically in group 1 (10 of 13 in total, P = 0.011), and significantly more tuberosities were resorbed in group 1 (9 of 12 in total, P = 0.012). Significant differences in functional results among healed versus failed tuberosity fixation were observed for activity of daily living (P = 0.05), range of motion (P = 0.002), strength (P = 0.01), the total score (P = 0.008), and the passive rotation amplitude (P = 0.04). CONCLUSION: In hemiarthroplasties for proximal humeral fractures, the reattachment of the tuberosities with cable wire and bone grafting gives consistently better radiographic and functional results than with suture fixation alone.

Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01

Allopurinol (ALP) hypersensitivity is a major cause of severe cutaneous adverse reactions and is strongly associated with the HLA-B*58:01 allele. However, it can occur in the absence of this allele with identical clinical manifestations. The immune mechanism of ALP-induced severe cutaneous adverse reactions is poorly understood, and the T cell-reactivity pattern in patients with or without the HLA-B*58:01 allele is not known. To understand the interactions among the drug, HLA, and TCR, we generated T cell lines that react to ALP or its metabolite oxypurinol (OXP) from HLA-B*58:01(+) and HLA-B*58:01(-) donors and assessed their reactivity. ALP/OXP-specific T cells reacted immediately to the addition of the drugs and bypassed intracellular Ag processing, which is consistent with the "pharmacological interaction with immune receptors" (p-i) concept. This direct activation occurred regardless of HLA-B*58:01 status. Although most OXP-specific T cells from HLA-B*58:01(+) donors were restricted by the HLA-B*58:01 molecule for drug recognition, ALP-specific T cells also were restricted to other MHC class I molecules. This can be explained by in silico docking data that suggest that OXP binds to the peptide-binding groove of HLA-B*58:01 with higher affinity. The ensuing T cell responses elicited by ALP or OXP were not limited to particular TCR Vβ repertoires. We conclude that the drug-specific T cells are activated by OXP bound to HLA-B*58:01 through the p-i mechanism.

Iron uptake and ferrokinetics in healthy male subjects of an iron-based oral phosphate binder (SBR759) labeled with the stable isotope 58 Fe

SBR759 is a novel polynuclear iron(III) oxide–hydroxide starch·sucrose·carbonate complex being developed for oral use in chronic kidney disease (CKD) patients with hyperphosphatemia on hemodialysis. SBR759 binds inorganic phosphate released by food uptake and digestion in the gastro-intestinal tract increasing the fecal excretion of phosphate with concomitant reduction of serum phosphate concentrations. Considering the high content of ∼20% w/w covalently bound iron in SBR759 and expected chronic administration to patients, absorption of small amounts of iron released from the drug substance could result in potential iron overload and toxicity. In a mechanistic iron uptake study, 12 healthy male subjects (receiving comparable low phosphorus-containing meal typical for CKD patients: ≤1000 mg phosphate per day) were treated with 12 g (divided in 3 × 4 g) of stable 58Fe isotope-labeled SBR759. The ferrokinetics of [58Fe]SBR759-related total iron was followed in blood (over 3 weeks) and in plasma (over 26 hours) by analyzing with high precision the isotope ratios of the natural iron isotopes 58Fe, 57Fe, 56Fe and 54Fe by multi-collector inductively coupled mass spectrometry (MC-ICP-MS). Three weeks following dosing, the subjects cumulatively absorbed on average 7.8 ± 3.2 mg (3.8–13.9 mg) iron corresponding to 0.30 ± 0.12% (0.15–0.54%) SBR759-related iron which amounts to approx. 5-fold the basal daily iron absorption of 1–2 mg in humans. SBR759 was well-tolerated and there was no serious adverse event and no clinically significant changes in the iron indices hemoglobin, hematocrit, ferritin concentration and transferrin saturation.